| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA1034: Anhydrous sodium thiosulfate for preventing hearing loss caused by cisplatin chemotherapy in people 1 month to 17 years with localised solid tumours |
|
Medicine details |
|
| Medicine name | anhydrous sodium thiosulfate |
| Formulation | 80 mg/mL solution for infusion |
| Reference number | 4144 |
| Indication | For preventing ototoxicity caused by cisplatin chemotherapy in people aged 1 month to 17 years with localised solid tumours |
| Company | Norgine Limited |
| BNF chapter | Ear, nose & oropharynx |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 18/10/24 |
| NICE guidance | |